Heart Closure Devices Market Report 2025

This Heart Closure Devices market report delivers an in-depth analysis of the market’s key characteristics, including size, growth potential, and segmentation. It provides a detailed breakdown of the market across major regions and leading countries, highlighting historical data and future growth projections. The report also examines the competitive landscape, market share insights, emerging trends, and strategic developments shaping the market.

The heart closure devices market size has grown rapidly in recent years. It will grow from $2.77 billion in 2024 to $3.1 billion in 2025 at a compound annual growth rate (CAGR) of 12.2%. The growth during the historical period can be attributed to factors such as greater awareness among healthcare providers, an increase in device approvals by regulatory authorities, favorable reimbursement policies, a rise in cardiovascular diseases, and a growing geriatric population.

The heart closure devices market size is expected to see rapid growth in the next few years. It will grow to $4.87 billion in 2029 at a compound annual growth rate (CAGR) of 11.9%. The projected growth in the forecast period is driven by factors including the rising incidence of congenital heart defects, increased adoption of MRI procedures, a growing number of heart strokes, higher incidence of atrial fibrillation, and an increasing preference for minimally invasive procedures. Key trends anticipated during this period include the integration of multi-functional devices, technological advancements, innovations in materials and design, the incorporation of imaging technologies, and the development of bioresorbable materials.

The increasing incidence of cardiovascular diseases (CVDs) is expected to drive the growth of the heart closure devices market. The rise in CVDs is attributed to factors such as aging, unhealthy lifestyle choices, genetic predisposition, and a higher prevalence of risk factors such as hypertension, diabetes, and obesity. Heart closure devices play a crucial role in minimizing complications caused by congenital heart defects by closing abnormal openings in the heart with minimal invasiveness, improving blood flow, and preventing further health issues. For instance, in May 2024, the Singapore Heart Foundation reported that cardiovascular diseases accounted for 26,885 deaths in 2023, with ischemic heart disease alone causing 5,302 deaths, showing a slight increase from the previous year. This growing incidence of cardiovascular diseases is driving the demand for heart closure devices.

Companies in the heart closure devices market are focusing on innovative solutions, such as patent foramen ovale (PFO) occlusion systems, to improve patient outcomes and reduce complications during procedures. PFO occlusion systems are designed to close a persistent hole between the right and left atria, which should have closed after birth but remains open in some individuals. For example, in September 2022, Abbott Laboratories launched the Amplatzer Talisman PFO Occlusion System, specifically for individuals with PFO, especially those who have experienced a stroke. The system features a pre-attached occluder for simplified procedures, a versatile 30mm size for better adaptability, and a fully recapturable design to ensure effective closure of the PFO and reduce the risk of future strokes.

In November 2023, Johnson & Johnson MedTech, a US-based medical device company, acquired Laminar Inc. for $400 million. This acquisition enhances Johnson & Johnson MedTech's product offerings in cardiac arrhythmia treatment, strengthens its market presence in left atrial appendage elimination devices, and enables innovation in stroke prevention solutions for patients with non-valvular atrial fibrillation. Laminar Inc. is a US-based manufacturer specializing in heart closure devices.

Major players in the heart closure devices market are Abbott Laboratories, Medtronic plc, Boston Scientific Corp., Lepu Medical Technology Ltd., Terumo Corporation, Edwards Lifesciences, Teleflex Incorporated, Merit Medical Systems Inc., Cordis Corporation, AtriCure Inc., Lifetech Scientific Corp., Sahajanand Medical Technologies, W. L. Gore And Associates Inc., Occlutech GmbH, NMT Medical Inc., Sorin Group Italia S.p.A., Vivasure Medical Limited, B Braun Interventional Systems, HeartStitch Inc., and MicroPort Scientific Corporation.

North America was the largest region in the heart closure devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in heart closure devices report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the heart closure devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Heart closure devices are sophisticated medical instruments designed to close holes or openings in the heart, often resulting from congenital defects or surgical procedures. These devices are used to treat conditions such as atrial septal defects (ASD), patent foramen ovale (PFO), and other structural heart issues. Typically, they are delivered through catheter-based procedures, providing a safer alternative to open-heart surgery.

The main types of heart closure devices include atrial septal defect (ASD) closure devices, ventricular septal defect (VSD) closure devices, patent foramen ovale (PFO) closure devices, left atrial appendage (LAA) closure devices, and others. ASD closure devices are implants used to seal abnormal openings in the septum between the heart's upper chambers and are usually deployed through minimally invasive catheter-based procedures. These devices are commonly made from materials such as nitinol, stainless steel, and other substances. Delivery methods include both transcatheter and surgical approaches, and these devices are utilized in various healthcare settings such as hospitals, ambulatory surgical centers (ASCs), and cardiac catheterization laboratories.

The heart closure devices market research report is one of a series of new reports that provides heart closure devices market statistics, including the heart closure devices industry global market size, regional shares, competitors with the heart closure devices market share, detailed heart closure devices market segments, market trends, and opportunities, and any further data you may need to thrive in the heart closure devices industry. This heart closure devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The heart closure devices market consists of sales of septal occluders, embolic protection devices, valvular closure devices, balloon occlusion devices, and transcatheter closure devices. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.